SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001140361-24-022025
Filing Date
2024-04-25
Accepted
2024-04-25 16:03:19
Documents
6
Period of Report
2024-06-05

Document Format Files

Seq Description Document Type Size
1 DEF 14A ny20020644x1_def14a.htm DEF 14A 763596
2 ny20020644x1_pc01.jpg GRAPHIC 614456
3 ny20020644x1_pc02.jpg GRAPHIC 531913
4 ny20020644x1_pvp01.jpg GRAPHIC 83041
5 ny20020644x1_pvp02.jpg GRAPHIC 83152
6 sig_douglaslove.jpg GRAPHIC 11471
  Complete submission text file 0001140361-24-022025.txt   2587053
Mailing Address 1400 SIERRA POINT PARKWAY BLDG C, SUITE 200 BRISBANE CA 94005
Business Address 1400 SIERRA POINT PARKWAY BLDG C, SUITE 200 BRISBANE CA 94005 (650)-822-5500
Annexon, Inc. (Filer) CIK: 0001528115 (see all company filings)

IRS No.: 275414423 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-39402 | Film No.: 24876135
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)